Mineralys Therapeutics, Inc..
MLYS.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and kidney disease. Their lead product candidate, lorundrostat, is an aldosterone synthase inhibitor being developed for the treatment of uncontrolled hypertension. The c...Show More
Better Health for All
0
No evidence available to assess Mineralys Therapeutics, Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
No evidence available to assess Mineralys Therapeutics, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No relevant data was found in the provided article to assess Mineralys Therapeutics, Inc. against the 'Fair Pay & Worker Respect' ethical value.
1
Therefore, no KPIs could be scored.
Fair Trade & Ethical Sourcing
0
No evidence available to assess Mineralys Therapeutics, Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
-40
Mineralys Therapeutics, Inc. has a formal policy for accounting complaints, adopted on January 17, 2023.
1
This policy includes a hotline, email, and direct reporting to the Audit Committee, emphasizing confidentiality and anonymity for employee complaints, but not guaranteeing confidentiality for non-employee complaints.
2
The company also has an anti-corruption and anti-bribery policy that explicitly states compliance with the U.S. Foreign Corrupt Practices Act (FCPA) and other anti-bribery laws in jurisdictions where it operates.
3
This policy applies globally to all directors, officers, and employees across its controlled subsidiaries, affiliates, partnerships, ventures, and business associations, and is available in multiple languages.
4
An investigation by the Schall Law Firm is underway into potential securities law violations related to the company's Q2 2024 financial results, but no specific details or evidence of violations have been presented.
5
Kind to Animals
-70
The company conducts animal testing for medical analysis and clinical research.
1
No specific details on the scope, strength, or enforcement of its animal testing policy are provided, nor is there information on its commitment to reducing or replacing animal testing.
2
The company does not provide data on the number of animals used in testing.
3
Furthermore, no information is given on the company's efforts to develop animal-free alternatives, or the percentage of its R&D budget invested in such technologies.
4
No War, No Weapons
0
The provided articles do not contain any specific, concrete data points or information relevant to Mineralys Therapeutics, Inc.'s association with arms manufacturing, military contracts, conflict facilitation, or peacebuilding initiatives. The articles primarily focus on the company's ESG risk rating, corporate governance documents, and its core business as a clinical-stage biopharmaceutical company developing medicines for hypertension and kidney disease. Therefore, no KPIs under the 'No War, No Weapons' value can be scored based on the evidence provided.
Planet-Friendly Business
0
The provided articles, including SEC filings and ESG summary reports, do not contain specific quantitative data points for any of the Planet-Friendly Business KPIs. Information regarding carbon emissions, renewable energy use, water consumption, waste diversion, green building certifications, or climate-related targets and initiatives is consistently noted as 'no data found' or 'not applicable'.
1
Therefore, no KPIs can be scored based on the evidence provided.
Respect for Cultures & Communities
0
No specific data points or facts related to 'Respect for Cultures & Communities' were found in the provided articles. The articles primarily cover investor rights, general ESG risk ratings, or product-related information, and explicitly state a lack of specific metrics concerning community engagement, cultural sensitivity, or partnerships with local or indigenous groups.
1
Safe & Smart Tech
0
No specific, concrete evidence was found in the provided articles to assess MLYS.US against any of the 'Safe & Smart Tech' KPIs. The articles either pertained to other companies
1
,
2
or contained general corporate information without specific data points related to data protection, cybersecurity, or responsible AI practices for Mineralys Therapeutics, Inc.
3
,
4
Zero Waste & Sustainable Products
0
No evidence available to assess Mineralys Therapeutics, Inc. on Zero Waste & Sustainable Products.